RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
156 hedge funds and large institutions have $1.02B invested in Revance Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 59 reducing their positions, and 17 closing their positions.
Holders
156
Holders Change
+5
Holders Change %
+3.31%
% of All Funds
2.47%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
46
Reduced
59
Closed
17
Calls
$27.5M
Puts
$9.97M
Net Calls
+$17.5M
Net Calls Change
+$15.6M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$13M |
| 2 |
2
Franklin Resources
San Mateo,
California
|
$43.2M |
| 3 |
3
D.E. Shaw & Co
New York
|
$16.5M |
| 4 |
4
HighTower Advisors
Chicago,
Illinois
|
$24M |
| 5 |
5
Jennison Associates
New York
|
$47.6M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
Rockefeller Capital Management
New York
| $0 | 45 | – | – |
|
|
JGC
177
J. Goldman & Co
New York
| – | – | – | – |
|
|
T
178
TCWP
Beachwood,
Ohio
| $0 | 39 | +39 | New |
|